Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Decibel Therapeutics, Inc. (DBTX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/21/2023 |
4
| Kapusta Matthew C (Director) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 10,000 shares
@ $0 Granted 10,000 options to buy
@ $3.34, valued at
$33.4k
|
|
03/17/2023 |
4
| Reid Laurence (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 195,000 shares
@ $0 Granted 72,000 options to buy
@ $3.73, valued at
$268.6k
|
|
01/30/2023 |
4
| Trask Anna (Chief People Officer) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 105,000 shares
@ $0 Granted 45,000 options to buy
@ $3.12, valued at
$140.4k
|
|
01/30/2023 |
4
| Lee John Jui-Jen (Chief Development Officer) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 120,000 shares
@ $0 Granted 45,000 options to buy
@ $3.12, valued at
$140.4k
|
|
10/12/2022 |
4
| MCLAUGHLIN KEVIN F (Director) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $2.88, valued at
$57.6k
|
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Carson William H. (Director) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 10,000 options to buy
@ $2.3, valued at
$23k
|
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/28/2022 |
4
| Trask Anna (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 52,500 options to buy
@ $3.5, valued at
$183.8k
|
|
02/28/2022 |
4
| Leiderman Elisabeth (CFO) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 52,500 options to buy
@ $3.5, valued at
$183.8k
|
|
02/28/2022 |
4
| Lee John Jui-Jen (Chief Development Officer) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 52,500 options to buy
@ $3.5, valued at
$183.8k
|
|
02/28/2022 |
4
| Reid Laurence (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 187,500 options to buy
@ $3.5, valued at
$656.3k
|
|
01/04/2022 |
4
| Trask Anna (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Sold 1 shares
@ $5.04, valued at
$5 Sold 377 shares
@ $5.03, valued at
$1.9k
|
|
12/06/2021 |
4
| Trask Anna (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Sold 4,913 shares
@ $6.3695, valued at
$31.3k
Sold 378 shares
@ $6.3352, valued at
$2.4k
|
|
12/06/2021 |
4
| Nochur Sara (Director) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $6.2, valued at
$124k
|
|
12/06/2021 |
4
| FINGER ALISON CECILY (Director) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $6.2, valued at
$124k
|
|
11/04/2021 |
4
| Trask Anna (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Sold 378 shares
@ $8.3392, valued at
$3.2k
|
|
11/03/2021 |
4
| Trask Anna (SEE REMARKS) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Sold 4,913 shares
@ $8.31, valued at
$40.8k
|
|
10/15/2021 |
4
| Trask Anna (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Sold 5,364 shares
@ $7.5468, valued at
$40.5k
|
|
09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Carson William H. (Director) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $8.42, valued at
$168.4k
|
|
03/08/2021 |
4
| Schroder Adveq Technology IX S.C.S. (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Converted 524,328 shares
@ $0 Converted 524,328 shares
@ $0 Converted 6,625,001 preferred shares
@ $0 Converted 6,625,001 preferred shares
@ $0 |
|
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2021 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Converted 546,421 shares
@ $0 Bought 575,000 shares
@ $18, valued at
$10.4M
Converted 2,896,032 preferred shares
@ $0 |
|
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|